Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
Derangère V, Fumet JD, Boidot R, Bengrine L, Limagne E, Chevriaux A, Vincent J, Ladoire S, Apetoh L, Rébé C, Ghiringhelli F.
Derangère V, et al. Among authors: bengrine l.
Oncotarget. 2016 Feb 23;7(8):9309-21. doi: 10.18632/oncotarget.7008.
Oncotarget. 2016.
PMID: 26824184
Free PMC article.